In her role as Director, M&C – MSK Innovation & New Ventures, Jill Fraser leads Marketing & Communications for all aspects of the MSK Commercialization Ecosystem, including the Office of Entrepreneurship & Commercialization (OEC), MSK Ventures, and Clinical Trial-related innovation.
Jill has worked at MSK since 2009 and has held a variety of different roles, including leading the Life Sciences & Emerging Technologies team in MSK’s M&C department and serving as Director of Strategic Marketing for Research and Technology Management. Previously, she founded and directed a strategic communications and marketing boutique firm that consulted with global companies at key growth junctures.
Earlier, Jill was a financial journalist, serving as a Staff Writer at Forbes, Finance Editor at Inc., and Columnist at The New York Times and The New York Observer. She has written a number of books, including White-Collar Sweatshop: The Deterioration of Work and Its Rewards in Corporate America. She holds a BA degree in English Literature from Swarthmore College.